We are pleased to share the publication of the KDIGO 2026 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD), a comprehensive update to the 2012 guideline. Read the guideline in @Kidney_Int: kdigo.co/KDIGO-Anemia-in-CKD… Visit the KDIGO Anemia in CKD Guideline website to download the guideline, executive summary, and news release: kdigo.org/guidelines/anemia-… Co-chaired by Dr. Jodie Babitt (US) and Dr. Marcello Tonelli (CA), the guideline provides evidence-based recommendations for diagnosing and managing anemia across the CKD continuum, including dialysis and kidney transplantation. “This guideline represents a major step forward in how we approach anemia in CKD,” said Dr. Babitt. “It emphasizes a systematic evaluation of anemia and iron deficiency, clearer guidance on when and how to use oral and intravenous iron, and integrates new evidence on emerging therapies while reinforcing the need to avoid overtreatment and to prioritize safety and shared decision-making.” “This guideline reflects a decade of new evidence and the increasing complexity of anemia management in people with chronic kidney disease,” said Dr. Tonelli. “We evaluated a large body of randomized trial data across iron therapies, ESAs, HIF-PHIs, and transfusion strategies, with careful attention to both benefits and harms, to support consistent, evidence-informed anemia care across diverse healthcare systems, resource settings, and patient populations worldwide.” #anemia #CKD